Literature DB >> 6387400

Nitrofurantoin-resistant mutants of Escherichia coli: isolation and mapping.

S S Sastry, R Jayaraman.   

Abstract

Mutants of Escherichia coli resistant to nitrofurantoin have been isolated. The mutations, designated nfnA and nfnB were introduced individually into a multiply auxotrophic E. coli F- strain and mapped by conjugation and transduction. nfnA is located at 79.8 min and nfnB at 13.0 min on the E. coli chromosome.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6387400     DOI: 10.1007/bf00328076

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  13 in total

1.  The reduction of Furacin by cell-free extracts of Furacin-resistant and parent-susceptible strains of Escherichia coli.

Authors:  R E ASNIS
Journal:  Arch Biochem Biophys       Date:  1957-01       Impact factor: 4.013

2.  Genetics of nitrofurazone resistance in Escherichia coli.

Authors:  D R McCalla; C Kaiser; M H Green
Journal:  J Bacteriol       Date:  1978-01       Impact factor: 3.490

3.  A model for three-point analysis of random general transduction.

Authors:  T T Wu
Journal:  Genetics       Date:  1966-08       Impact factor: 4.562

Review 4.  Linkage map of Escherichia coli K-12, edition 7.

Authors:  B J Bachmann
Journal:  Microbiol Rev       Date:  1983-06

5.  Type I nitroreductases of Escherichia coli.

Authors:  D W Bryant; D R McCalla; M Leeksma; P Laneuville
Journal:  Can J Microbiol       Date:  1981-01       Impact factor: 2.419

Review 6.  The pharmacokinetics of nitrofurantoin and its related bioavailability.

Authors:  J D Conklin
Journal:  Antibiot Chemother (1971)       Date:  1978

Review 7.  Drug therapy reviews: nitrofurantoin.

Authors:  R Gleckman; S Alvarez; D W Joubert
Journal:  Am J Hosp Pharm       Date:  1979-03

8.  Nifurzide, a nitrofuran antiinfectious agent: interaction with Escherichia coli cells.

Authors:  A Delsarte; M Faway; J M Frère; J Coyette; C M Calberg-Bacq; E Heinen
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

9.  Mode of action of nitrofurazone.

Authors:  D R McCalla; A Reuvers; C Kaiser
Journal:  J Bacteriol       Date:  1970-12       Impact factor: 3.490

10.  Inhibitors of nitrofuran reduction in Escherichia coli: evidence for their existence, partial purification, binding of nitrofurantoin in vitro, and implications for nitrofuran resistance.

Authors:  S S Sastry; R Jayaraman
Journal:  Arch Biochem Biophys       Date:  1985-01       Impact factor: 4.013

View more
  7 in total

Review 1.  Linkage map of Escherichia coli K-12, edition 10: the traditional map.

Authors:  M K Berlyn
Journal:  Microbiol Mol Biol Rev       Date:  1998-09       Impact factor: 11.056

Review 2.  Linkage map of Escherichia coli K-12, edition 8.

Authors:  B J Bachmann
Journal:  Microbiol Rev       Date:  1990-06

3.  Oxygen-insensitive nitroreductases: analysis of the roles of nfsA and nfsB in development of resistance to 5-nitrofuran derivatives in Escherichia coli.

Authors:  J Whiteway; P Koziarz; J Veall; N Sandhu; P Kumar; B Hoecher; I B Lambert
Journal:  J Bacteriol       Date:  1998-11       Impact factor: 3.490

4.  Identification of the genes encoding NAD(P)H-flavin oxidoreductases that are similar in sequence to Escherichia coli Fre in four species of luminous bacteria: Photorhabdus luminescens, Vibrio fischeri, Vibrio harveyi, and Vibrio orientalis.

Authors:  S Zenno; K Saigo
Journal:  J Bacteriol       Date:  1994-06       Impact factor: 3.490

5.  Evolution of drug resistance in Salmonella panama isolates in Chile.

Authors:  A M Cordano; R Virgilio
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

6.  Nifurtimox activation by trypanosomal type I nitroreductases generates cytotoxic nitrile metabolites.

Authors:  Belinda S Hall; Christopher Bot; Shane R Wilkinson
Journal:  J Biol Chem       Date:  2011-02-23       Impact factor: 5.157

7.  E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954.

Authors:  S O Vass; D Jarrom; W R Wilson; E I Hyde; P F Searle
Journal:  Br J Cancer       Date:  2009-05-19       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.